IL1B and COVID-19: Studies of COVID-19 patients also showed significant increases in proinflammatory cytokines and chemokines, including IL-6, IL-1β, TNF-α, and granulocyte–macrophage colony-stimulating factor, in patients’ plasma, with much higher levels in the plasma of critically ill patients [40].